KCA 098
KCA 098 is an orally active benzofuroquinoline derivative. KCA 098 can inhibit bone resorption and stimulat bone formation of chick embryo. KCA 098 can increase calcium and phosphorus content as well as the amount of force required to break the femur from ovariectomized rats. KCA 098 can be used for the research of bone diseases[1].
Product Specifications
CAS Number
129794-24-7
UNSPSC
12352005
Target
Drug Derivative
Related Pathways
Others
Field of Research
Metabolic Disease
Smiles
O=C(N(C)C)OC1=CC=C2C(OC(C3=C(N4)C=C(OC(N(C)C)=O)C=C3)=C2C4=O)=C1
Molecular Formula
C21H19N3O6
Molecular Weight
409.39
References & Citations
[1]Kojima M, et al. Effect of KCA-098, a new benzofuroquinoline derivative, on bone mineral metabolism. Biol Pharm Bull. 1994 Apr;17 (4) :504-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15234738 1 Vial
Lentiviral mouse Zfp248 shRNA (UAS) - Lentiviral mouse Zfp248 shRNA (UAS) (100)
Sign In for Pricing
View Details 